Influence of Body Mass Index and Gender on Growth Hormone (GH) Responses to GH-Releasing Hormone Plus Arginine and Insulin Tolerance Tests
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The aim of this study is to assess whether gender and body mass index (BMI) should be considered in developing thresholds to define GH deficiency, using GH responses to GHRH + arginine (ARG) stimulation and insulin tolerance test (ITT). Thirty-nine healthy subjects (19 males, 20 females; ages 21–50 yr) underwent GHRH + ARG, and another 27 subjects (19 males, 8 females; ages 20–49 yr) underwent ITT. Peak GH response was significantly higher (P = 0.005) after GHRH + ARG than with ITT, and this difference could not be explained by age, gender, or BMI. Peak GH response was negatively correlated with BMI in both tests (GHRH + ARG, r = −0.76; and ITT, r = −0.65). Peak GH response to GHRH + ARG was higher in females than males (P = 0.004; ratio = 2.4), but it was attenuated after eliminating the influence of BMI (P = 0.13; ratio = 1.6). No significant gender differences were found in peak GH responses to ITT, which could be due to the smaller number of female subjects studied. GH response to GHRH + ARG and ITT stimulation is sensitive to BMI differences and less so to gender differences. A higher BMI is associated with a depressed GH response to both stimulation tests. BMI should therefore be considered as a factor when defining the diagnostic cut-off points in the assessment of GH deficiency, whereas whether gender should be likewise used is inconclusive from this study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the GH response to GHRHϩARG, and to all known GH provocative stimuli, significantly declines with increasing BMI in adults (221, 222); thus, the use of a non-BMI-related cutoff in obese subjects causes a high percentage of false-positive results (203).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [222]
Citations
Cites
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“GHD patients also have potentially increased cardiovascular mortality (2).”
Background; (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.2.379 · Cited by 655
ZADIK, Z., CHALEW, A., McCARTER, R. J., MEISTAS, M., & KOWARSKI, A. A. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-3-513 · Cited by 598
WEISSBERGER, A. J., HO, K. K. Y., & LAZARUS, L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-374 · Cited by 514
VELDHUIS, J. D., IRANMANESH, A., HO, K. K. Y., WATERS, M. J., JOHNSON, M. L., & LIZARRALDE, G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-51 · Cited by 480 · cited 2×
“Obesity is known to influence the GH response to the provocative tests (5, 6), but body mass index (BMI) is not considered in the current peak GH cut-off points used in the diagnosis of GHD.”
BackgroundSensitivity and specificity of six tests for the diagnosis of adult GH deficiency
Biller, B. M. K., Samuels, M. H., Zagar, A., Cook, D. M., Arafah, B. M., Bonert, V., Stavrou, S., Kleinberg, D. L., Chipman, J. J., & Hartman, M. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8509 · Cited by 423
van den Berg, G., Veldhuis, J. D., Frölich, M., & Roelfsema, F. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.7.8675561 · Cited by 293
Arginine-Initiated Release of Human Growth Hormone: Factors Modifying the Response in Normal Man
Merimee, T. J., Rabinowitz, D., & Fineberg, S. E. (1969) · New England Journal of Medicine · doi:10.1056/nejm196906262802603 · Cited by 208 · cited 1×
“(36, 37) reported the gender difference in GH responses to ARG.”
BackgroundCASANUEVA, F. F., VILLANUEVA, L., DIEGUEZ, C., DIAZ, Y., CABRANES, J. A., SZOKE, B., SCANLON, M. F., SCHALLY, A. V., & FERNANDEZ-CRUZ, A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-4-634 · Cited by 206
Basal Plasma Growth Hormone Levels in Man: New Evidence for Rhythmicity of Growth Hormone Secretion*
WINER, L. M., SHAW, M. A., & BAUMANN, G. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-6-1678 · Cited by 194
Pulsatile growth hormone release in normal women during the menstrual cycle
Faria, A. C. S., Bekenstein, L. W., Booth, R. A., Vaccaro, V. A., Asplin, C. M., Veldhuls, J. D., Thorner, M. O., & Evans, W. S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02270.x · Cited by 194 · cited 1×
“(29) reported a positive correlation between maximal GH-pulse amplitude and serum estradiol level throughout the menstrual cycle.”
BackgroundFriend, K. E. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.6.2250 · Cited by 190
The Effect of Free Fatty Acids on Growth Hormone(GH)-Releasing Hormone-Mediated GH Secretion in Man*
IMAKI, T., SHIBASAKI, T., SHIZUME, K., MASUDA, A., HOTTA, M., KIYOSAWA, Y., JIBIKI, K., DEMURA, H., TSUSHIMA, T., & LING, N. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-2-290 · Cited by 173
Gharib, H., Cook, D. M., Saenger, P. H., Bengtsson, B.-A., Feld, S., Nippoldt, T. B., Rodbard, H. W., Seibel, J. A., Vance, M. L., Zimmerman, D., et al. (2003) · Endocrine Practice · doi:10.4158/ep.9.1.64 · Cited by 158 · cited 6×
“• Influence of BMI and Gender on GH Responses J Clin Endocrinol Metab, March 2005, 90(3):1563–1569 1567”
BackgroundMethodInfluentialBellantoni, M. F. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2848 · Cited by 146
LANG, I., SCHERNTHANER, G., PIETSCHMANN, P., KURZ, R., STEPHENSON, J. M., & TEMPL, H. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-535 · Cited by 130
Mauras, N., Rogol, A. D., & Veldhuis, J. D. (1990) · Pediatric Research · doi:10.1203/00006450-199012000-00018 · Cited by 127 · cited 1×
“Short-term therapy with low-dose estrogen was shown to double the GH production rate in prepubertal girls with Turner’s syndrome (11).”
BackgroundCORDIDO, F., DIEGUEZ, C., & CASANUEVA, F. F. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-5-1361 · Cited by 104
Comparisons among old and new provocative tests of GH secretion in 178 normal adults
Aimaretti, G., Baffoni, C., DiVito, L., Bellone, S., Grottoli, S., Maccario, M., Arvat, E., Camanni, F., & Ghigo, E. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1420347 · Cited by 104 · cited 2×
“(14) compared 10 GH-provocative tests in 178 normal subjects (ages 20–50 yr, 15% ideal body weight).”
BackgroundResultGender differences in secretory activity of the human somatotropic (growth hormone) axis
Veldhuis, J. D. (1996) · European Journal of Endocrinology · doi:10.1530/eje.0.1340287 · Cited by 102 · cited 1×
“This is unfortunate because the regulatory mechanisms of GH secretion in humans are sexually dimorphic (7), and estrogen has well-known priming effects on GH-provocative tests in children and postmenopausal women (8–12).”
BackgroundPritzlaff-Roy, C. J., Widemen, L., Weltman, J. Y., Abbott, R., Gutgesell, M., Hartman, M. L., Veldhuis, J. D., & Weltman, A. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01018.2001 · Cited by 87
Gender influences counterregulatory hormone responses to hypoglycemia
Diamond, M. P., Jones, T. W., Caprio, S., Hallarman, L., Connolly-Diamond, M., Addabbo, M., Tamborlane, W. V., & Sherwin, R. S. (1993) · Metabolism · doi:10.1016/0026-0495(93)90152-e · Cited by 77
Ghigo, E., Massimo, P., Boffano, G. M., Arvat, E., Valente, F., Maccario, M., Mazza, E., & Camanni, F. (1992) · Metabolism · doi:10.1016/0026-0495(92)90220-5 · Cited by 75
PONTIROLI, A. E., LANZI, R., MONTI, L. D., SANDOLI, E., & POZZA, G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-2-492 · Cited by 67
Cordido, F., Alvarez-Castro, P., Isidro, M., Casanueva, F., & Dieguez, C. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490117 · Cited by 62 · cited 2×
“Obesity is known to influence the GH response to the provocative tests (5, 6), but body mass index (BMI) is not considered in the current peak GH cut-off points used in the diagnosis of GHD.”
BackgroundBray, M. J., Vick, T. M., Shah, N., Anderson, S. M., Rice, L. W., Iranmanesh, A., Evans, W. S., & Veldhuis, J. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7647 · Cited by 56 · cited 1×
“Estrogen is likely to modulate the inhibitory effect of l-arginine on hypothalamic somatostatin and potentiates the GHRH-induced GH secretion (39).”
BackgroundInteraction of free fatty acids and arginine on growth hormone secretion in man
Maccario, M., Massimo, P., Loche, S., Cappa, M., Martina, V., Camanni, F., & Ghigo, E. (1994) · Metabolism · doi:10.1016/0026-0495(94)90249-6 · Cited by 46
Influence of obesity and body fat distribution on growth hormone kinetics in humans
Langendonk, J. G., Meinders, A. E., Burggraaf, J., Frölich, M., Roelen, C. A. M., Schoemaker, R. C., Cohen, A. F., & Pijl, H. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.5.e824 · Cited by 44 · cited 1×
“also contribute to the low GH response in obesity (6, 20).”
BackgroundPeino, R., Cordido, F., Peñalva, A., Álvarez, C. V., Diéguez, C., & Casanueva, F. F. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772549 · Cited by 42
Acipimox enhances spontaneous growth hormone secretion in obese women
Kok, P., Buijs, M. M., Kok, S. W., van Ierssel, I. H. A. P., Frölich, M., Roelfsema, F., Voshol, P. J., Meinders, A. E., & Pijl, H. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00595.2003 · Cited by 41
Bray, M. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.3143 · Cited by 40
Effects of Aging and Estradiol Supplementation on GH Axis Dynamics in Women
Lieman, H. J. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3918 · Cited by 39
O’Keane, V., & Dinan, T. G. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.1.1618997 · Cited by 39
Wideman, L., Weltman, J. Y., Patrie, J. T., Bowers, C. Y., Shah, N., Story, S., WELTMAN, A. L., & Veldhuis, J. D. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.4.r1455 · Cited by 38 · cited 1×
“(38) studied the gender effect of l-arginine and GHRP-2 on GH release in 18 young, nonobese subjects (nine men and nine TABLE 2.”
BackgroundOzata, M., Dieguez, C., & Casanueva, F. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020122 · Cited by 36
Fluctuations of human growth hormone secretion during menstrual cycle: Response to arginine
Merimee, T. J., Fineberg, S. E., & Tyson, J. E. (1969) · Metabolism · doi:10.1016/0026-0495(69)90095-x · Cited by 33 · cited 1×
“(36, 37) reported the gender difference in GH responses to ARG.”
BackgroundLee, E. J. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.8.2495 · Cited by 32
Arvat, E., Cappa, M., Casanueva, F. F., Diéguez, C., Ghigo, E., Nicolosi, M., Valcavi, R., & Zini, M. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.2.8432781 · Cited by 28
Diagnosis and Management of Adult Growth Hormone Deficiency
Ho, K. K. Y. (2000) · Endocrine · doi:10.1385/endo:12:2:189 · Cited by 7 · cited 1×
“A PATIENTS WITH GH deficiency (GHD) usually present with nonspecific signs and symptoms such as fatigue, change of body composition (increase in body fat, decrease in muscle mass, decrease in bone density), poor well-being, and depression (1).”
BackgroundCorsello, S. M., TOFANI, A., Casa, S. D., Rota, C. A., Sciuto, R., Colasanti, S., Barini, A., & Barbarino, A. (2008) · Neuroendocrinology · doi:10.1159/000126230 · Cited by 5
Cited by
Molitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
“increasing BMI has been shown (35), an analysis of dif-”
InfluentialSchneider, H. J., Aimaretti, G., Kreitschmann-Andermahr, I., Stalla, G.-K., & Ghigo, E. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60673-4 · Cited by 336
Modulation of growth hormone action by sex steroids
Meinhardt, U. J., & Ho, K. K. Y. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02676.x · Cited by 225
Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
Cook, D. M., Yuen, K. C. J., Biller, B. M. K., Kemp, S. F., Vance, M. L., Cook, D. M., Yuen, K. C. J., Biller, B. M. K., Kemp, S. F., Vance, M. L., et al. (2009) · Endocrine Practice · doi:10.4158/ep.15.s2.1 · Cited by 179
Metadata
- Authors
- Qu, X.-D., Gaw Gonzalo, I. T., Al Sayed, M. Y., Cohan, P., Christenson, P. D., Swerdloff, R. S., Kelly, D. F., & Wang, C.
- Affiliations
- University of California, Los Angeles (US)
- Divisions of Endocrinology (X.-D.Q., I.T.G.G., M.Y.A.S., P.C., P.D.C., R.S.S., C.W.), Los Angeles, California 90024
- Corresponding author
- Wang, Christina
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-03-01
- Volume
- 90
- Issue
- 3
- Pages
- 1563-1569
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2023061057
- Semantic Scholar
- 75ac21a1deb0893ba4c3d4d8ee11be4670b3a39a
- Cited by
- 103
- References
- 40
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 3 · 2015: 7 · 2014: 4 · 2013: 3 · 2012: 6
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsches Krebsforschungszentrum
- National Institutes of Health (1k23rr017298-01, 5t32dk007571-25, 5r01ns040777-05)
- University of California, Los Angeles
- National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK07571)
- National Institute of Neurological Disorders and Stroke (R01 NS 40777)
- National Center for Research Resources ((M01 RR00865), M01RR000865, K23 RR 17298)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- growth hormone deficiency, body mass index, sex differences, insulin tolerance test, growth hormone response, diagnostic thresholds, obesity
- MeSH terms
- Adult, Arginine, Diagnostic Techniques, Endocrine, Female, Humans, Insulin, Insulin Resistance, Male, Metabolic Diseases, Middle Aged, Oligopeptides, Sex Characteristics, Body Mass Index, Human Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.